CA ATC C09CA01 · updated 2 Nov 2026
Losartan shortage in Canada
Is there a Losartan shortage in Canada?
Yes. As of 2 Nov 2026, 14 Losartan products are reported short in Canada, the first since 30 Apr 2018. The company estimate for the return is 1 Jan 2028. Main reason: manufacturing problem.
Also short in Italy, Spain, Belgium, Sweden, Japan. All countries.
Affected products in Canada
| Country | Product | Company | Since | Expected back | Reason |
|---|---|---|---|---|---|
| CA | APO-LOSARTAN (100 BTL & 30 BLS) | APOTEX INC | 30 Apr 2018 | not given | Manufacturing problem Disruption of the manufacture of the drug |
| CA | APO-LOSARTAN (100 BTL) | APOTEX INC | 28 May 2018 | not given | Manufacturing problem Disruption of the manufacture of the drug |
| CA | APO-LOSARTAN (100 BTL) | APOTEX INC | 9 Jul 2018 | not given | Manufacturing problem Disruption of the manufacture of the drug |
| CA | SEPTA-LOSARTAN (100 tabs) | SEPTA PHARMACEUTICALS INC | 3 Oct 2018 | not given | Other Other (Please describe in comments) |
| CA | APO-LOSARTAN (30BLS) | APOTEX INC | 24 Dec 2018 | not given | Manufacturing problem Disruption of the manufacture of the drug |
| CA | SEPTA-LOSARTAN (100s) | SEPTA PHARMACEUTICALS INC | 3 Jan 2019 | not given | Other Other (Please describe in comments) |
| CA | SEPTA-LOSARTAN (100 tabs) | SEPTA PHARMACEUTICALS INC | 15 Jan 2019 | not given | Other Other (Please describe in comments) |
| CA | BIO-LOSARTAN (100) | BIOMED PHARMA | 18 Feb 2019 | not given | Distribution or logistics Delay in shipping of the drug |
| CA | BIO-LOSARTAN (100) | BIOMED PHARMA | 12 Mar 2019 | not given | Increased demand Demand increase for the drug |
| CA | BIO-LOSARTAN (100) | BIOMED PHARMA | 25 Jul 2019 | not given | Manufacturing problem Disruption of the manufacture of the drug |
| CA | JAMP-LOSARTAN (3x10) | JAMP PHARMA CORPORATION | 23 Dec 2024 | 1 Jan 2028 | Manufacturing problem Disruption of the manufacture of the drug |
| CA | JAMP-LOSARTAN (100) | JAMP PHARMA CORPORATION | 26 Feb 2026 | 1 Jan 2028 | Manufacturing problem Disruption of the manufacture of the drug |
| CA | JAMP-LOSARTAN (Bottle / Bouteille 100) | JAMP PHARMA CORPORATION | 12 Mar 2026 | 1 Jan 2028 | Manufacturing problem Disruption of the manufacture of the drug |
| CA | JAMP-LOSARTAN (100) | JAMP PHARMA CORPORATION | 27 Mar 2026 | 1 Jan 2028 | Manufacturing problem Disruption of the manufacture of the drug |
Source
Health Canada, Health Product Shortages Canada. Official list. Mandatory company reports since 2017: actual and anticipated shortages, plus products about to be discontinued.